Related Experiment Video
Updated: Oct 29, 2026

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
Published on: August 2, 2017
Sex-specific adverse neonatal outcomes and umbilical cord arterial ph at birth: a population-based cohort study
Wazhma Nassery Akel1, Sara Abdulilah2, Mehreen Zaigham2,3
1Department of Obstetrics and Gynaecology, Skåne University Hospital, Malmö, 205 01, Sweden. wazhma.nassery_akel@med.lu.se.
Background:
Biological sex may influence neonatal vulnerability to adverse perinatal outcomes, but sex-related differences in these outcomes remain underexplored. Male neonates may be more susceptible to perinatal asphyxia, metabolic acidosis, preterm birth, and morbidity, possibly due to sex-specific placental differences and inflammatory responses. Umbilical cord arterial pH (UApH) < 7.05 is used in Sweden to define neonatal acidemia, associated with poor outcomes. This study aimed to investigate the association between neonatal sex and adverse outcomes, focusing on UApH.
Methods:
This retrospective multicenter cohort study used data from the Swedish Perinatal Revision South Register (1995-2015). The cohort included live-born, singleton, vaginal births. Neonatal and maternal data were extracted, and logistic regression models compared outcomes between male and female neonates, adjusting for maternal age, gestational age, and birth weight.
Results:
Among 87 840 neonates, 51.6% were male. Male neonates had significantly higher adjusted odds of adverse outcomes compared with females: UApH < 7.05 (OR 1.18, 95% CI 1.07-1.30; P < 0.001), Apgar score < 7 at 5 min (OR 1.33, 95% CI 1.14-1.56; P < 0.001), CPAP use (OR 1.66, 95% CI 1.46-1.87; P < 0.001), NICU admission (OR 1.51, 95% CI 1.43-1.60; P < 0.001), hypoxic-ischemic encephalopathy (OR 2.24, 95% CI 1.29-3.90; P = 0.002) and central nervous system disease (OR 1.52, 95% CI 1.30-1.76; P < 0.001).
Conclusions:
Male neonatal sex was associated with several adverse perinatal outcomes, including acidemia and neurological complications. These findings contribute to the understanding of sex-related differences in neonatal vulnerability and warrant further investigation.
Trial Registration:
Not applicable.